Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Haiti(0/week)
    • Guyana(0/week)
    • Honduras(0/week)
    • Jamaica(0/week)
    • Netherlands Antilles(0/week)
    • View all (0/week)
  • News
    • United States(999/week)
    • Manufacturing(502/week)
    • Energy(360/week)
    • Technology(962/week)
    • Other Manufacturing(315/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

Amneal Pharmaceuticals LLC

Jul 29, 2019
Alkermes Announces Settlement With Amneal Over VIVITROL® Patent Dispute
Apr 02, 2019
Amneal Names Pradeep Bhadauria as Chief Scientific Officer
Apr 01, 2019
Amneal Announces Agreement with Zentiva to Divest Creo Pharma
Jan 22, 2019
Amneal Names Accomplished Finance Executive Todd P. Branning As Chief Financial Officer
Jan 14, 2019
Amneal Announces Approval of Rivastigmine Transdermal System
Nov 12, 2018
Amneal Completes Transition Agreement With Lannett Company To Begin Commercialization Of Levothyroxine On December 1st
Oct 24, 2018
Amneal Announces Issuance of New Patent for IPX203, an Investigational Extended-Release Formulation of Carbidopa-Levodopa
Oct 23, 2018
Amneal Announces Approval and Launch of Clobazam Tablets and Clobazam Oral Suspension
Oct 19, 2018
Amneal Announces Approval of Carmustine for Injection USP, 100 mg/vial - Preparing for Launch
Sep 12, 2018
Amneal Announces FDA Approval and Launch of Generic Chlorpromazine Hydrochloride Tablets USP and Approval of Methylergonovine Maleate Tablets USP
Aug 31, 2018
Amneal Announces Partnership with American Regent on Generic Makena® and Progress on its Business Plan with Additional ANDA Approvals and Launches
Aug 20, 2018
Amneal Announces 10-Year Licensing and Supply Agreement with Jerome Stevens Pharmaceuticals, Inc. for Levothyroxine
Jul 23, 2018
Amneal Announces FDA Approval and Launch of Generic Potassium Chloride Oral Solution
Jun 29, 2018
Amneal Announces Favorable Ruling Regarding Patent Validity for Zomig® (zolmitriptan) Nasal Spray
Jun 20, 2018
Amneal Announces Patent Litigation Settlement Agreement with Actavis Concerning Rytary®
May 30, 2018
Amneal Announces FDA Approval of Cyclophosphamide for Injection USP, Generic to Cytoxan®
May 18, 2018
Amneal Pharmaceuticals Celebrates Combination by Ringing Opening Bell at New York Stock Exchange
May 17, 2018
Amneal Announces FDA Approval and Launch of Generic Welchol® (Colesevelam HCl) Tablets, 625 mg
May 15, 2018
Amneal Introduces First Generic for Mephyton® (Phytonadione) Tablets, 5mg
May 11, 2018
Amneal Announces Actions to Streamline Operations and Capture Cost Synergies
  •  
  • Page 1
  • ››

Latest News

Sep 4, 2025

Fluor Awarded U.S. Army Europe’s Logistics Support Services Contract in Bavaria

Sep 4, 2025

Silgan Announces Pricing of New Senior Notes Offering

Sep 4, 2025

Babcock & Wilcox Enterprises Regains Compliance With NYSE Continued Listing Standard

Sep 4, 2025

NextDecade Announces 1.5 MTPA LNG Sale and Purchase Agreement with EQT from Rio Grande LNG Train 5

Sep 4, 2025

Primoris Services Corporation to Participate in Investor Conferences

Sep 4, 2025

BrilliA Inc Declares Cash Dividend of $0.13 per Class A Share

Sep 4, 2025

nVent Expands Data Center Solutions Manufacturing with New U.S. Production Facility

Sep 4, 2025

Myers Industries Announces Quarterly Dividend

View all News

Agenda

30
September
PortugalTroia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United KingdomLondon, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2025 EPICOS
Made by Wedia